IDO1-expressing MDSCs have been shown to accumulate in chronic lymphocytic leukemia (CLL) patients, suppress T cells activity significantly, and induce suppressive Tregs in vitro [123,124]. Here, IDO1 is linked to B-cell chronic lymphocytic leukemia.